Posted by Michael Wonder on 11 Feb 2018
Cancer patients waiting a year for Keytruda funding decision from PHARMAC
12 February 2018 - Hundreds of lung cancer patients whose lives could be saved by a new treatment labelled a "miracle drug" are still waiting for a funding decision a year after it was first lodged.
In February last year an application was lodged for funding for immunotherapy drug Keytruda to be used as an initial treatment for people with advanced non-small cell lung cancer and a high level of the protein PD-L1.
A year later, no decision has been made.
